Literature DB >> 15252124

Platelet adhesion signalling and the regulation of thrombus formation.

Jonathan M Gibbins1.   

Abstract

Platelets perform a central role in haemostasis and thrombosis. They adhere to subendothelial collagens exposed at sites of blood vessel injury via the glycoprotein (GP) Ib-V-IX receptor complex, GPVI and integrin alpha(2)beta(1). These receptors perform distinct functions in the regulation of cell signalling involving non-receptor tyrosine kinases (e.g. Src, Fyn, Lyn, Syk and Btk), adaptor proteins, phospholipase C and lipid kinases such as phosphoinositide 3-kinase. They are also coupled to an increase in cytosolic calcium levels and protein kinase C activation, leading to the secretion of paracrine/autocrine platelet factors and an increase in integrin receptor affinities. Through the binding of plasma fibrinogen and von Willebrand Factor to integrin alpha(IIb)beta(3), a platelet thrombus is formed. Although increasing evidence indicates that each of the adhesion receptors GPIb-V-IX and GPVI and integrins alpha(2)beta(1) and alpha(IIb)beta(3) contribute to the signalling that regulates this process, the individual roles of each are only beginning to be dissected. By contrast, adhesion receptor signalling through platelet endothelial cell adhesion molecule 1 (PECAM-1) is implicated in the inhibition of platelet function and thrombus formation in the healthy circulation. Recent studies indicate that understanding of platelet adhesion signalling mechanisms might enable the development of new strategies to treat and prevent thrombosis.

Entities:  

Mesh:

Year:  2004        PMID: 15252124     DOI: 10.1242/jcs.01325

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  86 in total

1.  Enzymes that hydrolyze adenine nucleotides in platelets and polymorphisms in the alpha2 gene of integrin alpha2beta1 in patients with von Willebrand disease.

Authors:  Karen Freitas Santos; Vanessa Battisti; Maísa de Carvalho Corrêa; Thaís Rapachi Mann; Renata da Silva Pereira; Maria do Carmo Araújo; Alice Odete Brülê; Maria Rosa Chitolina Schetinger; Vera Maria Morsch
Journal:  Mol Cell Biochem       Date:  2010-03-25       Impact factor: 3.396

Review 2.  Thrombus formation in vivo.

Authors:  Bruce Furie; Barbara C Furie
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

3.  A genome- and phenome-wide association study to identify genetic variants influencing platelet count and volume and their pleiotropic effects.

Authors:  Khader Shameer; Joshua C Denny; Keyue Ding; Hayan Jouni; David R Crosslin; Mariza de Andrade; Christopher G Chute; Peggy Peissig; Jennifer A Pacheco; Rongling Li; Lisa Bastarache; Abel N Kho; Marylyn D Ritchie; Daniel R Masys; Rex L Chisholm; Eric B Larson; Catherine A McCarty; Dan M Roden; Gail P Jarvik; Iftikhar J Kullo
Journal:  Hum Genet       Date:  2013-09-12       Impact factor: 4.132

4.  Aegyptin displays high-affinity for the von Willebrand factor binding site (RGQOGVMGF) in collagen and inhibits carotid thrombus formation in vivo.

Authors:  Eric Calvo; Fuyuki Tokumasu; Daniella M Mizurini; Peter McPhie; David L Narum; José Marcos C Ribeiro; Robson Q Monteiro; Ivo M B Francischetti
Journal:  FEBS J       Date:  2009-12-15       Impact factor: 5.542

5.  Critical role for Syk in responses to vascular injury.

Authors:  Patrick Andre; Toshifumi Morooka; Derek Sim; Keith Abe; Clifford Lowell; Nisha Nanda; Suzanne Delaney; Gail Siu; Yibing Yan; Stan Hollenbach; Anjali Pandey; Huiyun Gao; Yunmei Wang; Kohsuke Nakajima; Sahil A Parikh; Can Shi; David Phillips; Whyte Owen; Uma Sinha; Daniel I Simon
Journal:  Blood       Date:  2011-08-31       Impact factor: 22.113

6.  Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation.

Authors:  M Endale; W M Lee; S M Kamruzzaman; S D Kim; J Y Park; M H Park; T Y Park; H J Park; J Y Cho; M H Rhee
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

7.  The Modifier of hemostasis (Mh) locus on chromosome 4 controls in vivo hemostasis of Gp6-/- mice.

Authors:  Yann Cheli; Deborah Jensen; Patrizia Marchese; David Habart; Tim Wiltshire; Michael Cooke; José A Fernandez; Jerry Ware; Zaverio M Ruggeri; Thomas J Kunicki
Journal:  Blood       Date:  2007-11-08       Impact factor: 22.113

8.  Site-specific effects of PECAM-1 on atherosclerosis in LDL receptor-deficient mice.

Authors:  Reema Goel; Benjamin R Schrank; Shikha Arora; Brian Boylan; Barbara Fleming; Hiroto Miura; Peter J Newman; Robert C Molthen; Debra K Newman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-31       Impact factor: 8.311

9.  Platelet-mediated metabolism of the common dietary flavonoid, quercetin.

Authors:  Bernice Wright; Trevor Gibson; Jeremy Spencer; Julie A Lovegrove; Jonathan M Gibbins
Journal:  PLoS One       Date:  2010-03-12       Impact factor: 3.240

Review 10.  Platelet receptors and signaling in the dynamics of thrombus formation.

Authors:  José Rivera; María Luisa Lozano; Leyre Navarro-Núñez; Vicente Vicente
Journal:  Haematologica       Date:  2009-03-13       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.